Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Neurology
    September 2021
  1. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    >> Share

  2. BUCIUC M, Josephs KA, Jones DT, Whitwell JL, et al
    Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012783.
    >> Share

    August 2021
  3. FRISON E, Proust-Lima C, Mangin JF, Habert MO, et al
    Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
    Neurology. 2021;97:e836-e848.
    >> Share

  4. SANDERS AE
    A Century-Old Problem: Cognition and Neuropsychiatric Symptoms in Alzheimer Disease.
    Neurology. 2021 Aug 20. pii: WNL.0000000000012616.
    >> Share

  5. EIKELBOOM WS, van den Berg E, Singleton EH, Baart SJ, et al
    Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Neurology. 2021 Aug 19. pii: WNL.0000000000012598.
    >> Share

  6. LI J
    Alzheimer's Villanelle.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012612.
    >> Share

  7. PETERSEN RC
    Mild Cognitive Impairment Criteria in Alzheimer's Disease Neuroimaging Initiative: Meeting Biological Expectations.
    Neurology. 2021 Aug 2. pii: WNL.0000000000012588.
    >> Share

    July 2021
  8. TAO Q, Alvin Ang TF, Akhter-Khan SC, Itchapurapu IS, et al
    Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous Apolipoprotein E varepsilon4 Carriers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012512.
    >> Share

  9. BOCANCEA DI, Catharina van Loenhoud A, Groot C, Barkhof F, et al
    Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods: A Systematic Review and Meta-analysis.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012499.
    >> Share

  10. GROTHE MJ, Moscoso A, Ashton NJ, Karikari TK, et al
    Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012513.
    >> Share

  11. POGGESI A
    Resilience and Resistance in Aging and Alzheimer Disease: Another Step to Fill the Gap Between Clinicians and Researchers.
    Neurology. 2021 Jul 15. pii: WNL.0000000000012500.
    >> Share

  12. WILSON RS, Wang T, Yu L, Grodstein F, et al
    Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia.
    Neurology. 2021 Jul 14. pii: WNL.0000000000012388.
    >> Share

  13. SALLOWAY S, Cummings J
    Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease.
    Neurology. 2021 Jul 7. pii: WNL.0000000000012451.
    >> Share

    June 2021
  14. BUCIUC M, Duffy JR, Machulda MM, Graff-Radford J, et al
    Clinical, Imaging, and Pathologic Characteristics of Patients With Right Versus Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012322.
    >> Share

    May 2021
  15. HUGHES TM, Hajjar I
    Is Late-onset Alzheimer Disease Spelled "ATV(N)"?
    Neurology. 2021 May 24. pii: WNL.0000000000012259.
    >> Share

  16. DONADIO V, Wang Z, Incensi A, Rizzo G, et al
    In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
    Neurology. 2021;96:e2513-e2524.
    >> Share

  17. FRIEDMAN LG, McKeehan N, Hara Y, Cummings JL, et al
    Value-Generating Exploratory Trials in Neurodegenerative Dementias.
    Neurology. 2021;96:944-954.
    >> Share

  18. MAYBLYUM DV, Becker JA, Jacobs HIL, Buckley RF, et al
    Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.
    Neurology. 2021 May 5. pii: WNL.0000000000012108.
    >> Share

  19. BALLARINI T, Melo van Lent D, Brunner J, Schroder A, et al
    Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age.
    Neurology. 2021 May 5. pii: WNL.0000000000012067.
    >> Share

  20. BELLAVER B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, et al
    Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021 May 5. pii: WNL.0000000000012109.
    >> Share

  21. HAZRATI LN, Schwab N
    Embracing the Unknown in the Diagnosis of Traumatic Encephalopathy Syndrome.
    Neurology. 2021;96:835-836.
    >> Share

    April 2021
  22. BOERWINKLE AH, Wisch JK, Chen CD, Gordon BA, et al
    Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012123.
    >> Share

  23. KARCESKI S
    The Effects of Long-term Medication Use in Alzheimer Disease.
    Neurology. 2021;96:e2247-e2250.
    >> Share

  24. XU H, Garcia-Ptacek S, Jonsson L, Wimo A, et al
    Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Neurology. 2021;96:e2220-e2230.
    >> Share

  25. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
    Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
    >> Share

  26. HAMILTON CA, Matthews FE, Donaghy PC, Taylor JP, et al
    Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease.
    Neurology. 2021 Apr 19. pii: WNL.0000000000012024.
    >> Share

  27. HOWARD E, Irwin DJ, Rascovsky K, Nevler N, et al
    Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
    Neurology. 2021;96:e1855-e1864.
    >> Share

    March 2021
  28. QIAN J, Betensky RA, Hyman BT, Serrano-Pozo A, et al
    Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.
    Neurology. 2021 Mar 26. pii: WNL.0000000000011883.
    >> Share

  29. GOTTESMAN RF, Hamilton R
    Recruiting Diverse Populations in Clinical Trials: How Do We Overcome Selection Bias?
    Neurology. 2021;96:509-510.
    >> Share

  30. KANG SH, Kim ME, Jang H, Kwon H, et al
    Amyloid Positivity in Alzheimer/Subcortical-Vascular Spectrum.
    Neurology. 2021 Mar 15. pii: WNL.0000000000011833.
    >> Share

  31. SMIRNOV DS, Galasko D, Hiniker A, Edland S, et al
    Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease.
    Neurology. 2021 Mar 15. pii: WNL.0000000000011772.
    >> Share

  32. BARKHOF BF, Pressman PS
    Time Is of the Essence: Early Detection of Incipient Alzheimer Pathology.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011739.
    >> Share

    February 2021
  33. ROBINSON-PAPP J, Saylor D
    HIV in the Brain: From Devastating Dementia to White Matter Hyperintensities.
    Neurology. 2021 Feb 26. pii: WNL.0000000000011735.
    >> Share

  34. HUYNH K, Piguet O, Kwok J, Dobson-Stone C, et al
    Clinical and Biological Correlates of White Matter Hyperintensities in Patients with Behavioral-variant Frontotemporal Dementia and Alzheimer Disease.
    Neurology. 2021 Feb 17. pii: WNL.0000000000011638.
    >> Share

  35. THERRIAULT J, Pascoal TA, Benedet AL, Tissot C, et al
    Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;96:e975-e985.
    >> Share

  36. RENTZ DM, Papp KV, Mayblyum DV, Sanchez JS, et al
    Association of Digital Clock Drawing with PET Amyloid and Tau Pathology in Normal Older Adults.
    Neurology. 2021 Feb 15. pii: WNL.0000000000011697.
    >> Share

  37. DETERS K, Napolioni V, Sperling RA, Greicius MD, et al
    Amyloid PET imaging in self-identified non-Hispanic Blacks from the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011599.
    >> Share

  38. FERREIRA D, Nordberg A, Westman E
    Author Response: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:238.
    >> Share

  39. ULEMAN JF, Melis RJF, Olde Rikkert MGM
    Reader Response: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:237-238.
    >> Share

  40. GANESH A, Galetta S
    Editors' Note: Biological Subtypes of Alzheimer Disease: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:237.
    >> Share

    January 2021
  41. JOSEPH-MATHURIN N, Wang G, Kantarci K, Jack CR Jr, et al
    Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease.
    Neurology. 2021 Jan 25. pii: WNL.0000000000011542.
    >> Share

  42. SAJJADI SA, Ash S, Cappa S
    Glass half full: Preservation of memory in Alzheimer-related primary progressive aphasia.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011404.
    >> Share

  43. MESULAM MM, Coventry C, Kuang A, Bigio EH, et al
    Memory resilience in Alzheimer's disease with primary progressive aphasia.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011397.
    >> Share

  44. BLAZHENETS G, Frings L, Ma Y, Sorensen A, et al
    Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011521.
    >> Share

  45. JAGUST WJ, Landau SM
    Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011524.
    >> Share

  46. TRELLE AN, Carr VA, Wilson EN, Swarovski MS, et al
    Association of CSF Biomarkers with Hippocampal-dependent Memory in Preclinical Alzheimer Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011477.
    >> Share

  47. THERRIAULT J, Pascoal TA, Savard M, Benedet AL, et al
    Topographic Distribution of Amyloid-beta, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease.
    Neurology. 2021;96:e81-e92.
    >> Share

    December 2020
  48. KNOPMAN DS, Jagust WJ
    Alzheimer Disease Spectrum: Syndrome and Etiology from Clinical and PET Imaging Perspectives.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011415.
    >> Share

  49. KOYAMA AK, Irwin DJ
    Alzheimer disease biomarker profiles in dementia with Lewy bodies: Does A plus T spell D-L-B?
    Neurology. 2020;95:1076-1077.
    >> Share

  50. GICAS KM, Honer WG, Wilson RS, Boyle PA, et al
    Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes.
    Neurology. 2020;95:e3303-e3312.
    >> Share

  51. PETTIGREW C, Soldan A, Wang J, Wang MC, et al
    Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline.
    Neurology. 2020;95:e3093-e3103.
    >> Share

  52. PALMQVIST S, Eshaghi A
    Spatial distribution of tau and beta-amyloid pathologies and their role in different Alzheimer's disease phenotypes.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011272.
    >> Share

  53. LA JOIE R, Visani AV, Lesman-Segev OH, Baker SL, et al
    Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011270.
    >> Share

    November 2020
  54. KARCESKI S
    How a buildup of abnormal proteins in the brain may be the key to understanding Alzheimer disease.
    Neurology. 2020;95:e2951-e2953.
    >> Share

  55. YOUNAN D, Wang X, Casanova R, Barnard R, et al
    PM2.5 associated with gray matter atrophy reflecting increased Alzheimers risk in older women.
    Neurology. 2020 Nov 18. pii: WNL.0000000000011149.
    >> Share

  56. ILLAN-GALA I, Lleo A, Karydas A, Staffaroni AM, et al
    Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease.
    Neurology. 2020 Nov 16. pii: WNL.0000000000011226.
    >> Share

  57. GRAFF-RADFORD J, Knopman D, Jones D
    Author response: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:846.
    >> Share

  58. ALLALI G, Laticevschi T
    Reader response: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:845-846.
    >> Share

  59. SIEGLER JE 3RD, Galetta S
    Editors' note: Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2020;95:845.
    >> Share

    October 2020
  60. KIM HR, Lee T, Choi JK, Jeong Y, et al
    Genetic variants beyond amyloid and tau associated with cognitive decline: A cohort study.
    Neurology. 2020;95:e2366-e2377.
    >> Share

  61. WEIGAND AJ, Bondi MW, Thomas KR, Campbell NL, et al
    Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.
    Neurology. 2020;95:e2295-e2304.
    >> Share

  62. KERCHNER GA, Filippi M
    Abeta-PET pathology accumulation index: Ready for the clinic?
    Neurology. 2020 Oct 19. pii: WNL.0000000000011060.
    >> Share

  63. LEUZY A, Lilja J, Buckley CJ, Ossenkoppele R, et al
    Derivation and utility of an Abeta-PET pathology accumulation index to estimate Abeta load.
    Neurology. 2020 Oct 19. pii: WNL.0000000000011031.
    >> Share

  64. BENNETT DA, Knopman DS
    Extending Alzheimer disease biomarker studies into the Hispanic community.
    Neurology. 2020;95:665-666.
    >> Share

  65. NAG S, Barnes LL, Yu L, Wilson RS, et al
    Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents.
    Neurology. 2020;95:e2056-e2064.
    >> Share

  66. GERTJE EC, van Westen D, Panizo C, Mattsson-Carlgren N, et al
    Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011046.
    >> Share

  67. KAPASI A, Yu L, Boyle PA, Barnes LL, et al
    Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging.
    Neurology. 2020;95:e1951-e1962.
    >> Share

  68. CATRICALA E, Polito C, Presotto L, Esposito V, et al
    Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010967.
    >> Share

    September 2020
  69. HANES J, Kovac A, Kvartsberg H, Kontsekova E, et al
    Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias.
    Neurology. 2020 Sep 24. pii: WNL.0000000000010814.
    >> Share

  70. BRENOWITZ WD, Besser LM, Kukull WA, Keene CD, et al
    Clinician-judged hearing impairment and associations with neuropathologic burden.
    Neurology. 2020;95:e1640-e1649.
    >> Share

  71. SAN LEE J, Lee H, Park S, Choe Y, et al
    Association between APOE epsilon2 and Abeta burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment.
    Neurology. 2020 Sep 14. pii: WNL.0000000000010811.
    >> Share

  72. CIRRITO JR, Wallace CE, Yan P, Davis TA, et al
    Effect of Escitalopram on Abeta levels and plaque load in an Alzheimer mouse model.
    Neurology. 2020 Sep 10. pii: WNL.0000000000010733.
    >> Share

  73. SCHREIBER S, DiFrancesco JC
    Impaired occipital cerebrovascular reactivity as a biomarker for vascular beta-amyloid.
    Neurology. 2020;95:415-416.
    >> Share

  74. GUZMAN-VELEZ E, Martinez J, Papp K, Baena A, et al
    Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.
    Neurology. 2020;95:e1312-e1321.
    >> Share

  75. BRENOWITZ WD, Filshtein TJ, Yaffe K, Walter S, et al
    Association of genetic risk for Alzheimer disease and hearing impairment.
    Neurology. 2020 Sep 2. pii: WNL.0000000000010709.
    >> Share

  76. LUO J, Agboola F, Grant E, Masters CL, et al
    Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
    Neurology. 2020 Sep 1. pii: WNL.0000000000010747.
    >> Share

    August 2020
  77. HUANG J, Zuber V, Matthews PM, Elliott P, et al
    Sleep, major depressive disorder and Alzheimer's disease: A Mendelian randomisation study.
    Neurology. 2020 Aug 19. pii: WNL.0000000000010463.
    >> Share

  78. KIM JW, Byun MS, Lee JH, Yi D, et al
    Serum albumin and beta-amyloid deposition in the human brain.
    Neurology. 2020;95:e815-e826.
    >> Share

  79. MOFRAD RB, Tijms BM, Scheltens P, Barkhof F, et al
    Sex differences in CSF biomarkers vary by Alzheimer's disease stage and APOE epsilon4 genotype.
    Neurology. 2020 Aug 11. pii: WNL.0000000000010629.
    >> Share

  80. VAN DER ZANDE JJ, Gouw AA, van Steenoven I, van de Beek M, et al
    Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
    Neurology. 2020;95:e662-e670.
    >> Share

  81. LAM AD, Sarkis RA, Pellerin KR, Jing J, et al
    Association of epileptiform abnormalities and seizures in Alzheimer disease.
    Neurology. 2020 Aug 6. pii: WNL.0000000000010612.
    >> Share

  82. GONNEAUD J, Bedetti C, Binette AP, Benzinger TLS, et al
    Association of education with Abeta burden in preclinicial familial and sporadic Alzheimer disease.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010314.
    >> Share

    July 2020
  83. ARENAZA-URQUIJO EM EM, Salvado G, Operto G, Minguillon C, et al
    Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer's biomarkers.
    Neurology. 2020 Jul 31. pii: WNL.0000000000010527.
    >> Share

  84. BAUMEISTER SE, Karch A, Bahls M, Teumer A, et al
    Physical activity and risk of Alzheimer's disease: a two-sample Mendelian randomization study.
    Neurology. 2020 Jul 17. pii: WNL.0000000000010013.
    >> Share

  85. COLLIJ LE, Heeman F, Salvado G, Ingala S, et al
    Multi-tracer model for staging cortical amyloid deposition using PET imaging.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010256.
    >> Share

  86. SAIF N, Niotis K, Dominguez M, Hodes JF, et al
    Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial.
    Neurology. 2020 Jul 14. pii: WNL.0000000000009859.
    >> Share

  87. SUR S, Lin Z, Li Y, Yasar S, et al
    Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance.
    Neurology. 2020 Jul 13. pii: WNL.0000000000010133.
    >> Share

  88. SWITZER AR, Cheema I, McCreary CR, Zwiers A, et al
    Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment.
    Neurology. 2020 Jul 8. pii: WNL.0000000000010201.
    >> Share

  89. EBENAU JL, Timmers T, Wesselman LMP, Verberk IMW, et al
    ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project.
    Neurology. 2020;95:e46-e58.
    >> Share

  90. SAKAE N, Santos OA, Pedraza O, Litvan I, et al
    Clinical and pathologic features of cognitive-predominant corticobasal degeneration.
    Neurology. 2020;95:e35-e45.
    >> Share

  91. TEIPEL SJ, Fritz HC, Grothe MJ
    Neuropathological features associated with basal forebrain atrophy in Alzheimer's disease.
    Neurology. 2020 Jul 6. pii: WNL.0000000000010192.
    >> Share

  92. WOLTERS FJ, Chibnik LB, Waziry R, Anderson R, et al
    27-year time trends in dementia incidence in Europe and the US: the Alzheimer Cohorts Consortium.
    Neurology. 2020 Jul 1. pii: WNL.0000000000010022.
    >> Share

    June 2020
  93. TIBLE M, Sandelius A, Hoglund K, Brinkmalm A, et al
    Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease.
    Neurology. 2020 Jun 25. pii: WNL.0000000000010131.
    >> Share

  94. RAHMAN A, Schelbaum E, Hoffman K, Diaz I, et al
    Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
    Neurology. 2020 Jun 24. pii: WNL.0000000000009781.
    >> Share

  95. DHANA K, Evans DA, Rajan KB, Bennett DA, et al
    Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies.
    Neurology. 2020 Jun 17. pii: WNL.0000000000009816.
    >> Share

  96. BUCIUC M, Botha H, Murray ME, Schwarz CG, et al
    Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
    Neurology. 2020 Jun 9. pii: WNL.0000000000009722.
    >> Share

  97. QIN L, Zhu X, Friedland RP
    ApoE and mitochondrial dysfunction.
    Neurology. 2020;94:1009-1010.
    >> Share

    May 2020
  98. YIN J, Reiman EM, Beach TG, Serrano GE, et al
    Effect of ApoE isoforms on mitochondria in Alzheimer disease.
    Neurology. 2020 May 26. pii: WNL.0000000000009582.
    >> Share

  99. MATTSSON-CARLGREN N, Leuzy A, Janelidze S, Palmqvist S, et al
    The implications of different approaches to define AT(N) in Alzheimer disease.
    Neurology. 2020 May 12. pii: WNL.0000000000009485.
    >> Share

  100. JACOBS HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, et al
    The presubiculum links incipient amyloid and tau pathology to memory function in older persons.
    Neurology. 2020;94:e1916-e1928.
    >> Share

  101. BERNATH MM, Bhattacharyya S, Nho K, Barupal DK, et al
    Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers.
    Neurology. 2020 May 1. pii: WNL.0000000000009436.
    >> Share

    April 2020
  102. SMIRNOV DS, Galasko D, Edland SD, Filoteo JV, et al
    Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies.
    Neurology. 2020 Apr 24. pii: WNL.0000000000009434.
    >> Share

  103. SARYCHEVA T, Lavikainen P, Taipale H, Tiihonen J, et al
    Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009435.
    >> Share

  104. VILAPLANA E, Rodriguez-Vieitez E, Ferreira D, Montal V, et al
    Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease.
    Neurology. 2020 Apr 14. pii: WNL.0000000000009405.
    >> Share

  105. ARENAZA-URQUIJO EM, Przybelski SA, Machulda MM, Knopman DS, et al
    Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults.
    Neurology. 2020;94:e1571-e1579.
    >> Share

    March 2020
  106. BREITNER J, Meyer PF
    Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:594.
    >> Share

  107. ASHFORD JW
    Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:593-594.
    >> Share

  108. GANESH A, Galetta S
    Editors' note: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2020;94:593.
    >> Share

  109. DOECKE JD, Perez-Grijalba V, Fandos N, Fowler C, et al
    Total Abeta42/Abeta40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.
    Neurology. 2020 Mar 16. pii: WNL.0000000000009240.
    >> Share

  110. TERADA T, Obi T, Bunai T, Matsudaira T, et al
    In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
    Neurology. 2020 Mar 5. pii: WNL.0000000000009249.
    >> Share

  111. SWERDLOW RH
    Mitochondria in Alzheimer brains: A PET project shows complex changes.
    Neurology. 2020 Mar 5. pii: WNL.0000000000009236.
    >> Share

    February 2020
  112. FERREIRA D, Nordberg A, Westman E
    Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.
    Neurology. 2020 Feb 11. pii: WNL.0000000000009058.
    >> Share

  113. HAAKSMA ML, Eriksdotter M, Rizzuto D, Leoutsakos JS, et al
    Survival time tool to guide care planning in people with dementia.
    Neurology. 2020;94:e538-e548.
    >> Share

  114. MCSWEENEY M, Pichet Binette A, Meyer PF, Gonneaud J, et al
    Intermediate flortaucipir uptake is associated with Abeta-PET and CSF-tau in asymptomatic adults.
    Neurology. 2020 Feb 3. pii: WNL.0000000000008905.
    >> Share

    January 2020
  115. RESENDE EPF, Nolan AL, Petersen C, Ehrenberg AJ, et al
    Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes: Astrocytic tau, cognitive function, and Alzheimer disease.
    Neurology. 2020 Jan 30. pii: WNL.0000000000008937.
    >> Share

  116. HOLLAND TM, Agarwal P, Wang Y, Leurgans SE, et al
    Dietary flavonols and risk of Alzheimer dementia.
    Neurology. 2020 Jan 29. pii: WNL.0000000000008981.
    >> Share

  117. MARTERSTECK A, Sridhar J, Rader B, Coventry C, et al
    Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease.
    Neurology. 2020 Jan 22. pii: WNL.0000000000008960.
    >> Share

  118. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Author response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:144-145.
    >> Share

  119. NELSON P
    Reader response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143-144.
    >> Share

  120. SIEGLER JE 3RD, Galetta S
    Editors' note: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2020;94:143.
    >> Share

  121. WAZIRY R, Chibnik LB, Bos D, Ikram MK, et al
    Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature.
    Neurology. 2020 Jan 16. pii: WNL.0000000000008924.
    >> Share

  122. YU L, Boyle PA, Dawe RJ, Bennett DA, et al
    Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons.
    Neurology. 2020;94:e142-e152.
    >> Share

    December 2019
  123. SOLDAN A, Pettigrew C, Zhu Y, Wang MC, et al
    White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Neurology. 2019 Dec 30. pii: WNL.0000000000008864.
    >> Share

  124. CAVEDO E, Lista S, Houot M, Vergallo A, et al
    Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
    Neurology. 2019 Dec 4. pii: WNL.0000000000008696.
    >> Share

    November 2019
  125. HONDA T, Ohara T, Shinohara M, Hata J, et al
    Serum elaidic acid concentration and risk of dementia: The Hisayama Study.
    Neurology. 2019;93:e2053-e2064.
    >> Share

  126. GRAFF-RADFORD J, Gunter JL, Jones DT, Przybelski SA, et al
    Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008616.
    >> Share

  127. WEINTRAUB S, Teylan M, Rader B, Chan KCG, et al
    APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort.
    Neurology. 2019 Nov 8. pii: WNL.0000000000008666.
    >> Share

    October 2019
  128. NETH BJ
    Right brain: Art and the restoration of identity in dementia.
    Neurology. 2019;93:719-721.
    >> Share

  129. CHONG JSX, Jang H, Kim HJ, Ng KK, et al
    Amyloid and cerebrovascular burden divergently influence brain functional network changes over time.
    Neurology. 2019;93:e1514-e1525.
    >> Share

  130. SCHNEIDER LS, Geffen Y, Rabinowitz J, Thomas RG, et al
    Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial.
    Neurology. 2019;93:e1474-e1484.
    >> Share

  131. MIRZA SS, Saeed U, Knight J, Ramirez J, et al
    APOE varepsilon4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia.
    Neurology. 2019 Oct 1. pii: WNL.0000000000008377.
    >> Share

    August 2019

  132. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2019;93:371.
    >> Share

  133. BENDLIN BB, Zetterberg H
    Screening with a high precision blood-based assay for Alzheimer disease.
    Neurology. 2019 Aug 1. pii: WNL.0000000000008080.
    >> Share

    July 2019
  134. WOLTERS FJ, Zonneveld HI, Licher S, Cremers LGM, et al
    Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI.
    Neurology. 2019 Jul 31. pii: WNL.0000000000008003.
    >> Share

  135. QIU Y, Jacobs DM, Messer K, Salmon DP, et al
    Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features.
    Neurology. 2019 Jul 18. pii: WNL.0000000000007967.
    >> Share


  136. Clinical phenotype, atrophy, and small vessel disease in APOEepsilon2 carriers with Alzheimer disease.
    Neurology. 2019;93:135.
    >> Share

  137. INSEL PS, Weiner M, Mackin RS, Mormino E, et al
    Determining clinically meaningful decline in preclinical Alzheimer disease.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007831.
    >> Share

  138. HAN SD, Shinotoh H
    The search for meaning in preclinical Alzheimer disease clinical trials.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007817.
    >> Share

  139. BISCHOF GN, Jacobs HIL
    Subthreshold amyloid and its biological and clinical meaning: Long way ahead.
    Neurology. 2019;93:72-79.
    >> Share

  140. VAN LOENHOUD AC, van der Flier WM, Wink AM, Dicks E, et al
    Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
    Neurology. 2019 Jul 2. pii: WNL.0000000000007821.
    >> Share

    June 2019
  141. TAGHDIRI F, Multani N, Tarazi A, Naeimi SA, et al
    Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions.
    Neurology. 2019;92:e2717-e2726.
    >> Share

    May 2019
  142. VERMUNT L, van Paasen AJL, Teunissen CE, Scheltens P, et al
    Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal.
    Neurology. 2019 May 8. pii: WNL.0000000000007609.
    >> Share

    April 2019
  143. KARCESKI S, Karceski S
    Can naproxen slow the progression of Alzheimer disease?
    Neurology. 2019;92:e2181-e2184.
    >> Share

  144. KNOPMAN DS, Petersen RC, Jack CR Jr
    A brief history of "Alzheimer disease": Multiple meanings separated by a common name.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007583.
    >> Share

  145. ERICKSON CM, Schultz SA, Oh JM, Darst BF, et al
    KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD.
    Neurology. 2019;92:e1878-e1889.
    >> Share

  146. ARVANITAKIS Z, Capuano AW
    Author response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:732.
    >> Share

  147. LATTANZI S, Silvestrini M
    Reader response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:731.
    >> Share

  148. SIEGLER JE 3RD, Galetta S
    Editors' note: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:731.
    >> Share

  149. MEYER PF, Tremblay-Mercier J, Leoutsakos J, Madjar C, et al
    INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2019 Apr 5. pii: WNL.0000000000007232.
    >> Share

  150. HERSHEY LA, Lipton RB
    Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again?
    Neurology. 2019 Apr 5. pii: WNL.0000000000007233.
    >> Share

  151. KANG SW, Jeon S, Yoo HS, Chung SJ, et al
    Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007373.
    >> Share

  152. SOLDAN A, Pettigrew C, Fagan AM, Schindler SE, et al
    ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes.
    Neurology. 2019;92:e1567-e1579.
    >> Share

    March 2019
  153. SATHYAN S, Wang T, Ayers E, Verghese J, et al
    Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study.
    Neurology. 2019;92:e1427-e1434.
    >> Share

  154. CANNON-ALBRIGHT LA, Foster NL, Schliep K, Farnham JM, et al
    Relative risk for Alzheimer disease based on complete family history.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007231.
    >> Share

  155. VAN HARTEN AC
    Longevity gene KLOTHO may play a role in Alzheimer disease.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007302.
    >> Share

  156. VOS SJB, Duara R
    The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals.
    Neurology. 2019 Mar 6. pii: WNL.0000000000007223.
    >> Share

  157. MESULAM MM, Lalehzari N, Rahmani F, Ohm D, et al
    Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology.
    Neurology. 2019 Mar 6. pii: WNL.0000000000007247.
    >> Share

  158. PRESSMAN PS, Gola K, Shdo SM, Miller BL, et al
    Relative preservation of facial expression recognition in posterior cortical atrophy.
    Neurology. 2019;92:e1064-e1071.
    >> Share

    February 2019
  159. FEMMINELLA GD, Dani M, Wood M, Fan Z, et al
    Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume.
    Neurology. 2019 Feb 22. pii: WNL.0000000000007133.
    >> Share

  160. WILSON RS, Yang J, Yu L, Leurgans SE, et al
    Postmortem neurodegenerative markers and trajectories of decline in cognitive systems.
    Neurology. 2019;92:e831-e840.
    >> Share

  161. MORAN C, Beare R, Wang W, Callisaya M, et al
    Type 2 diabetes mellitus, brain atrophy, and cognitive decline.
    Neurology. 2019;92:e823-e830.
    >> Share

  162. BUCHMAN AS, Yu L, Wilson RS, Lim A, et al
    Physical activity, common brain pathologies, and cognition in community-dwelling older adults.
    Neurology. 2019;92:e811-e822.
    >> Share

  163. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2019;92:329-337.
    >> Share

    January 2019
  164. WHITWELL JL, Martin PR, Duffy JR, Clark HM, et al
    The influence of beta-amyloid on [(18)F]AV-1451 in semantic variant of primary progressive aphasia.
    Neurology. 2019 Jan 11. pii: WNL.0000000000006913.
    >> Share

  165. OSSENKOPPELE R, Smith R, Ohlsson T, Strandberg O, et al
    Associations between tau, Abeta, and cortical thickness with cognition in Alzheimer disease.
    Neurology. 2019 Jan 9. pii: WNL.0000000000006875.
    >> Share

  166. KANTARCI K, Jicha GA
    Development of (1)H MRS biomarkers for tracking early predementia Alzheimer disease.
    Neurology. 2019 Jan 4. pii: WNL.0000000000006839.
    >> Share

    December 2018
  167. HARA Y, McKeehan N, Fillit HM
    Translating the biology of aging into novel therapeutics for Alzheimer disease.
    Neurology. 2018 Dec 7. pii: WNL.0000000000006745.
    >> Share

    October 2018
  168. GROOT C, Sudre CH, Barkhof F, Teunissen CE, et al
    Clinical phenotype, atrophy, and small vessel disease in APOEepsilon2 carriers with Alzheimer disease.
    Neurology. 2018 Oct 19. pii: WNL.0000000000006503.
    >> Share

  169. KORK F, Jankowski J, Goswami A, Weis J, et al
    Golgin A4 in CSF and granulovacuolar degenerations of Alzheimer patients.
    Neurology. 2018 Oct 10. pii: WNL.0000000000006457.
    >> Share

    September 2018
  170. BRICKMAN AM, Tosto G, Gutierrez J, Andrews H, et al
    An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease.
    Neurology. 2018 Sep 14. pii: WNL.0000000000006310.
    >> Share

  171. MCDADE E, Wang G, Gordon BA, Hassenstab J, et al
    Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.
    Neurology. 2018 Sep 14. pii: WNL.0000000000006277.
    >> Share

  172. BENNETT DA
    An MRI biomarker of mixed pathology.
    Neurology. 2018 Sep 14. pii: WNL.0000000000006305.
    >> Share

    August 2018
  173. DICKSON DW, Heckman MG, Murray ME, Soto AI, et al
    APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology.
    Neurology. 2018 Aug 24. pii: WNL.0000000000006212.
    >> Share

  174. PETERSEN RC
    How early can we diagnose Alzheimer disease (and is it sufficient)? The 2017 Wartenberg lecture.
    Neurology. 2018 Aug 8. pii: WNL.0000000000006088.
    >> Share

  175. ASCHENBRENNER AJ, Gordon BA, Benzinger TLS, Morris JC, et al
    Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.
    Neurology. 2018 Aug 1. pii: WNL.0000000000006075.
    >> Share

    July 2018

  176. Age-dependent white matter inflammation and cognitive impairment in the TgAPP21 rat model of Alzheimer disease.
    Neurology. 2018;91:242.
    >> Share

  177. JANELIDZE S, Mattsson N, Stomrud E, Lindberg O, et al
    CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease.
    Neurology. 2018 Jul 27. pii: WNL.0000000000006082.
    >> Share

  178. JANG H, Bae JB, Dardiotis E, Scarmeas N, et al
    Differential effects of completed and incomplete pregnancies on the risk of Alzheimer disease.
    Neurology. 2018 Jul 18. pii: WNL.0000000000006000.
    >> Share

  179. ARVANITAKIS Z, Capuano AW, Lamar M, Shah RC, et al
    Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2018 Jul 11. pii: WNL.0000000000005951.
    >> Share

    June 2018
  180. STRAIN JF, Smith RX, Beaumont H, Roe CM, et al
    Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions.
    Neurology. 2018 Jun 29. pii: WNL.0000000000005864.
    >> Share

  181. MERLUZZI AP, Carlsson CM, Johnson SC, Schindler SE, et al
    Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia.
    Neurology. 2018 Jun 29. pii: WNL.0000000000005901.
    >> Share

  182. BENARROCH EE
    Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: Emerging mechanisms.
    Neurology. 2018 Jun 13. pii: WNL.0000000000005807.
    >> Share

    April 2018
  183. PASSAMONTI L, Rodriguez PV, Hong YT, Allinson KSJ, et al
    [(11)C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.
    Neurology. 2018 Apr 27. pii: WNL.0000000000005610.
    >> Share

  184. CUMMINGS JL, Cohen S, van Dyck CH, Brody M, et al
    ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease.
    Neurology. 2018 Apr 25. pii: WNL.0000000000005550.
    >> Share

  185. BERTI V, Walters M, Sterling J, Quinn CG, et al
    Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.
    Neurology. 2018 Apr 13. pii: WNL.0000000000005527.
    >> Share

  186. KERN S, Zetterberg H, Kern J, Zettergren A, et al
    Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.
    Neurology. 2018 Apr 13. pii: WNL.0000000000005476.
    >> Share

    March 2018
  187. ARENAZA-URQUIJO EM, Vemuri P
    Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies.
    Neurology. 2018 Mar 28. pii: WNL.0000000000005303.
    >> Share

    February 2018
  188. BENNETT DA, Gordon BA
    Alzheimer disease biomarkers and synucleinopathy.
    Neurology. 2018 Feb 21. pii: WNL.0000000000005171.
    >> Share

  189. MENDES A, Bertrand A, Lamari F, Colliot O, et al
    Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005165.
    >> Share

  190. JONES DT, Knopman DS, Graff-Radford J, Syrjanen JA, et al
    In vivo (18)F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms.
    Neurology. 2018 Feb 9. pii: WNL.0000000000005117.
    >> Share

  191. BOTHA H, Mantyh WG, Graff-Radford J, Machulda MM, et al
    Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005124.
    >> Share

  192. DAY GS, Gordon BA, Perrin RJ, Cairns NJ, et al
    In vivo [(18)F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005064.
    >> Share

  193. KNOPMAN DS
    Sifting through a failed Alzheimer trial: What biomarkers tell us about what happened.
    Neurology. 2018 Feb 2. pii: WNL.0000000000005073.
    >> Share

    January 2018
  194. AISEN PS
    Author response: A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2018;90:145.
    >> Share

  195. PIAZZA F
    Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2018;90:144-145.
    >> Share

  196. KARAM C, Griggs RC
    Editors' note: A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2018;90:144.
    >> Share

  197. MATTSSON N, Smith R, Strandberg O, Palmqvist S, et al
    Comparing (18)F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.
    Neurology. 2018 Jan 10. pii: WNL.0000000000004887.
    >> Share

    December 2017
  198. WILLIAMS DM, Karlsson IK, Pedersen NL, Hagg S, et al
    Circulating insulin-like growth factors and Alzheimer disease: A mendelian randomization study.
    Neurology. 2017 Dec 27. pii: WNL.0000000000004854.
    >> Share

  199. YASAR S, Whitmer R
    Statin use and risk of Alzheimer disease: A new view on an old relationship.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004837.
    >> Share

  200. SINYAVSKAYA L, Gauthier S, Renoux C, Dell'Aniello S, et al
    Comparative effect of statins on the risk of incident Alzheimer disease.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004818.
    >> Share

  201. GROOT C, van Loenhoud AC, Barkhof F, van Berckel BNM, et al
    Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease.
    Neurology. 2017 Dec 13. pii: WNL.0000000000004802.
    >> Share

  202. GONNEAUD J, Arenaza-Urquijo EM, Mezenge F, Landeau B, et al
    Increased florbetapir binding in the temporal neocortex from age 20 to 60 years.
    Neurology. 2017;89:2438-2446.
    >> Share

    November 2017
  203. GROTHE MJ, Barthel H, Sepulcre J, Dyrba M, et al
    In vivo staging of regional amyloid deposition.
    Neurology. 2017;89:2031-2038.
    >> Share

  204. CORRIVEAU RA, Koroshetz WJ, Gladman JT, Jeon S, et al
    Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004717.
    >> Share

    October 2017
  205. GAUTHIER S, Ng KP, Pascoal TA, Mathotaarachchi S, et al
    Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017;89:1931.
    >> Share

  206. LANDIN-ROMERO R, Kumfor F
    Letter re: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017;89:1931.
    >> Share

  207. RISACHER SL, Anderson WH, Charil A, Castelluccio PF, et al
    Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
    Neurology. 2017 Oct 25. pii: 10.1212/WNL.0000000000004670.
    >> Share

  208. WESTON PSJ, Poole T, Ryan NS, Nair A, et al
    Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
    Neurology. 2017 Oct 25. pii: 10.1212/WNL.0000000000004667.
    >> Share

  209. FILIPPI M, Basaia S, Canu E, Imperiale F, et al
    Brain network connectivity differs in early-onset neurodegenerative dementia.
    Neurology. 2017;89:1764-1772.
    >> Share

  210. BRENOWITZ WD, Hubbard RA, Keene CD, Hawes SE, et al
    Mixed neuropathologies and associations with domain-specific cognitive decline.
    Neurology. 2017;89:1773-1781.
    >> Share

  211. CHETELAT G, Murray ME
    Amyloid PET scan: Staging beyond reading?
    Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004678.
    >> Share

  212. KIEBOOM BCT, Licher S, Wolters FJ, Ikram MK, et al
    Serum magnesium is associated with the risk of dementia.
    Neurology. 2017;89:1716-1722.
    >> Share

  213. ROBERTS RO, Knopman DS, Syrjanen JA, Aakre JA, et al
    Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004652.
    >> Share

  214. GASBY D
    Alzheimer dementia's other victim: The spouse.
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004638.
    >> Share

  215. WEINER MW, Crane PK, Montine TJ, Bennett DA, et al
    Traumatic brain injury may not increase the risk of Alzheimer disease.
    Neurology. 2017 Oct 4. pii: 10.1212/WNL.0000000000004608.
    >> Share

    September 2017
  216. MEDAGLIA JD, Huang W, Segarra S, Olm C, et al
    Brain network efficiency is influenced by the pathologic source of corticobasal syndrome.
    Neurology. 2017;89:1373-1381.
    >> Share

  217. CASALETTO KB, Elahi FM, Bettcher BM, Neuhaus J, et al
    Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers.
    Neurology. 2017 Sep 22. pii: 10.1212/WNL.0000000000004569.
    >> Share

  218. NORTON DJ, Amariglio R, Protas H, Chen K, et al
    Subjective memory complaints in preclinical autosomal dominant Alzheimer disease.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004533.
    >> Share

    August 2017
  219. MOSCONI L, Berti V, Quinn C, McHugh P, et al
    Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004425.
    >> Share


  220. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.
    Neurology. 2017;89:980.
    >> Share

  221. SMITH R, Scholl M, Widner H, van Westen D, et al
    In vivo retention of 18F-AV-1451 in corticobasal syndrome.
    Neurology. 2017;89:845-853.
    >> Share

  222. LI G, Mayer CL, Morelli D, Millard SP, et al
    Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults.
    Neurology. 2017 Aug 18. pii: 10.1212/WNL.0000000000004392.
    >> Share

    July 2017
  223. BENUSSI A, Di Lorenzo F, Dell'Era V, Cosseddu M, et al
    Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia.
    Neurology. 2017 Jul 26. pii: 10.1212/WNL.0000000000004232.
    >> Share

  224. DONADIO V, Incensi A, Rizzo G, Capellari S, et al
    A new potential biomarker for dementia with Lewy bodies: Skin nerve alpha-synuclein deposits.
    Neurology. 2017;89:318-326.
    >> Share

  225. LAFAILLE-MAGNAN ME, Poirier J, Etienne P, Tremblay-Mercier J, et al
    Odor identification as a biomarker of preclinical AD in older adults at risk.
    Neurology. 2017;89:327-335.
    >> Share

  226. SPIRA AP, Ju YS
    Self-reported sleep and Alzheimer disease CSF biomarkers: A wake-up call.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004189.
    >> Share

  227. MOFFAT SD
    Author response: Long-term cortisol measures predict Alzheimer disease risk.
    Neurology. 2017;89:106.
    >> Share

  228. LATTANZI S, Silvestrini M
    Letter re: Long-term cortisol measures predict Alzheimer disease risk.
    Neurology. 2017;89:106.
    >> Share

    June 2017
  229. ZHAN X
    Author response: Gram-negative bacterial molecules associate with Alzheimer disease pathology.
    Neurology. 2017;88:2338.
    >> Share

  230. MENTE K
    Letter re: Gram-negative bacterial molecules associate with Alzheimer disease pathology.
    Neurology. 2017;88:2338.
    >> Share

  231. BUCKLEY RF, Schultz AP, Hedden T, Papp KV, et al
    Functional network integrity presages cognitive decline in preclinical Alzheimer disease.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004059.
    >> Share

  232. ALCOLEA D, Vilaplana E, Suarez-Calvet M, Illan-Gala I, et al
    CSF sAPPbeta, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004088.
    >> Share

    May 2017
  233. GIANNINI LAA, Irwin DJ, McMillan CT, Ash S, et al
    Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
    Neurology. 2017 May 17. pii: 10.1212/WNL.0000000000004034.
    >> Share

  234. BOOTS EA, Schultz SA, Clark LR, Racine AM, et al
    BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention.
    Neurology. 2017 May 3. pii: 10.1212/WNL.0000000000003980.
    >> Share

    April 2017
  235. SCHULTZ SA, Boots EA, Darst BF, Zetterberg H, et al
    Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD.
    Neurology. 2017;88:1650-1658.
    >> Share

  236. NG KP, Pascoal TA, Mathotaarachchi S, Chung CO, et al
    Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003916.
    >> Share

  237. PETERSEN RC, Thomas RG, Aisen PS, Mohs RC, et al
    Randomized controlled trials in mild cognitive impairment: Sources of variability.
    Neurology. 2017 Apr 5. pii: 10.1212/WNL.0000000000003907.
    >> Share

  238. RELKIN NR, Thomas RG, Rissman RA, Brewer JB, et al
    A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2017 Apr 5. pii: 10.1212/WNL.0000000000003904.
    >> Share

    March 2017
  239. PAPP KV, Rentz DM, Mormino EC, Schultz AP, et al
    Cued memory decline in biomarker-defined preclinical Alzheimer disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003812.
    >> Share

    February 2017
  240. DAY GS, Lim TS, Hassenstab J, Goate AM, et al
    Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003770.
    >> Share

  241. TOSTO G, Bird TD, Tsuang D, Bennett DA, et al
    Polygenic risk scores in familial Alzheimer disease.
    Neurology. 2017 Feb 17. pii: 10.1212/WNL.0000000000003734.
    >> Share

  242. IMTIAZ B, Tuppurainen M, Rikkonen T, Kivipelto M, et al
    Postmenopausal hormone therapy and Alzheimer disease: A prospective cohort study.
    Neurology. 2017 Feb 15. pii: 10.1212/WNL.0000000000003696.
    >> Share

  243. CHEN J, Yu JT, Wojta K, Wang HF, et al
    Genome-wide association study identifies MAPT locus influencing human plasma tau levels.
    Neurology. 2017;88:669-676.
    >> Share

  244. FRANZMEIER N, Duering M, Weiner M, Dichgans M, et al
    Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003711.
    >> Share

  245. KREISL WC, Lawrence R, Page E, Teich AF, et al
    11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003693.
    >> Share

    January 2017
  246. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    >> Share

  247. THOMAS AJ, Attems J, Colloby SJ, O'Brien JT, et al
    Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Neurology. 2017;88:276-283.
    >> Share

    December 2016
  248. ENNIS GE, An Y, Resnick SM, Ferrucci L, et al
    Long-term cortisol measures predict Alzheimer disease risk.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003537.
    >> Share

    November 2016
  249. MOKRY LE, Ross S, Morris JA, Manousaki D, et al
    Genetically decreased vitamin D and risk of Alzheimer disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003430.
    >> Share

  250. HOHMAN TJ, McLaren DG, Mormino EC, Gifford KA, et al
    Asymptomatic Alzheimer disease: Defining resilience.
    Neurology. 2016 Nov 4. pii: 10.1212/WNL.0000000000003397.
    >> Share

    October 2016
  251. KIKUCHI A, Okamura N, Hasegawa T, Harada R, et al
    In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Neurology. 2016 Oct 28. pii: 10.1212/WNL.0000000000003375.
    >> Share

  252. ZHAN X, Stamova B, Jin LW, DeCarli C, et al
    Gram-negative bacterial molecules associate with Alzheimer disease pathology.
    Neurology. 2016 Oct 26. pii: 10.1212/WNL.0000000000003391.
    >> Share

  253. WESTON PS, Nicholas JM, Lehmann M, Ryan NS, et al
    Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
    Neurology. 2016 Oct 12. pii: 10.1212/WNL.0000000000003322.
    >> Share

  254. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    >> Share

    September 2016
  255. MATTSSON N, Zetterberg H, Janelidze S, Insel PS, et al
    Plasma tau in Alzheimer disease.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003246.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016